- Trials with a EudraCT protocol (10)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
10 result(s) found for: Urosepsis.
Displaying page 1 of 1.
EudraCT Number: 2016-001427-30 | Sponsor Protocol Number: 276046 | Start Date*: 2016-06-28 | |||||||||||
Sponsor Name:University of Helsinki / CLUE Working Group | |||||||||||||
Full Title: Antibiotic prophylaxis before extracorporeal shock wave lithotripsy (APPEAL) | |||||||||||||
Medical condition: Prevention of urinary tract infections among patients undergoing extracorporeal shock wave lithotripsy for urinary stone disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-001486-21 | Sponsor Protocol Number: 276046 | Start Date*: 2021-11-26 | |||||||||||
Sponsor Name:University of Helsinki/CLUE working Group | |||||||||||||
Full Title: A Multicentre Randomised Control Trial Assessing the Efficacy of Antimicrobial Prophylaxis for Extracorporeal Shock Wave Lithotripsy on reducing Urinary Tract Infections | |||||||||||||
Medical condition: Nephrolithiasis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-001321-32 | Sponsor Protocol Number: 198809 | Start Date*: 2015-04-14 | |||||||||||
Sponsor Name:Department of Clinical Microbiology, Hvidovre Hospital | |||||||||||||
Full Title: The efficacy of pivmecillinam 3 days respectively 5 days t.i.d against community acquired uncomplicated urinary tract infections | |||||||||||||
Medical condition: Lower Uncomplicated Urinary Tract Infection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-001081-80 | Sponsor Protocol Number: NL22172 | Start Date*: 2008-06-20 |
Sponsor Name:Leiden University Medical Center | ||
Full Title: Relevance of Biomarkers and Clinical Predictors of Outcome in Unselected Population with Febrile Urinary Tract Infection at Primary Care and Emergency Department in a Prospective, Randomized Cohort... | ||
Medical condition: To determine whether a 7-day duration of antibiotic treatment is non inferior to 14-day standard duration of treatment in adults presenting at primary care or emergency department with febrile uri... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2020-004202-60 | Sponsor Protocol Number: CER-001-SEP_AKI_01 | Start Date*: 2021-01-13 | |||||||||||
Sponsor Name:CERENIS THERAPEUTICS | |||||||||||||
Full Title: A RAndomized pilot study comparing short-term CER-001 infusions at different doses to prevent Sepsis-induced acute kidney injury | |||||||||||||
Medical condition: Sepsis due to intra-abdominal cavity infection or urosepsis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-001332-26 | Sponsor Protocol Number: IJG-SCOUT-2021 | Start Date*: 2021-09-06 | |||||||||||
Sponsor Name:IDIAP Jordi Gol | |||||||||||||
Full Title: Clinical effectiveness and bacteriological eradication of 3 short-course antibiotic regimens and single-dose of fosfomicyn trometamol for lower urinary tract infections in adult women [SCOUT study]. | |||||||||||||
Medical condition: Uncomplicated Lower urinary tract infections (uLUTI) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-005112-37 | Sponsor Protocol Number: J&P 01/2007 draft4 | Start Date*: 2008-08-21 | |||||||||||
Sponsor Name:Medizinische Universität Wien, Abteilung für Interne Medizin I | |||||||||||||
Full Title: An randomized, controlled, investigator-blinded, prospective, mono-centre study to evaluate the efficacy of fosfomycin versus meropenem in patients with complicated urinary tract infections | |||||||||||||
Medical condition: This study will primarily address the question of the efficacy of intravenous fosfomycin 4 g b.i.d. in the therapy of patients presenting with complicated urinary tract infection. These data will b... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-001760-19 | Sponsor Protocol Number: THR-1442-C-476 | Start Date*: 2016-01-07 | |||||||||||
Sponsor Name:Theracos Sub, LLC | |||||||||||||
Full Title: A double blind placebo controlled study to evaluate the effects of bexagliflozin on hemoglobin A1c in patients with type 2 diabetes and increased risk of cardiovascular adverse events | |||||||||||||
Medical condition: Type II diabetes | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) DE (Completed) PL (Completed) DK (Completed) NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-003037-11 | Sponsor Protocol Number: 21839 | Start Date*: 2022-04-13 | |||||||||||
Sponsor Name:Bayer AG | |||||||||||||
Full Title: A parallel-group treatment, Phase 2, double-blind, three-arm study to assess efficacy and safety of finerenone plus empagliflozin compared with either finerenone or empagliflozin in participants wi... | |||||||||||||
Medical condition: Chronic kidney disease in type 2 diabetes mellitus | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) IT (Ongoing) NL (Ongoing) DK (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-005273-27 | Sponsor Protocol Number: VAC52416BAC3001 | Start Date*: 2021-09-07 | ||||||||||||||||
Sponsor Name:Janssen Vaccines & Prevention B.V | ||||||||||||||||||
Full Title: Randomized, Double-Blind, Placebo-controlled, Multicenter Phase 3 Study to Assess the Efficacy, Safety And Immunogenicity of Vaccination With ExPEC9V in the Prevention of Invasive Extraintestinal P... | ||||||||||||||||||
Medical condition: Invasive Extraintestinal Pathogenic Escherichia coli Disease | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Ongoing) ES (Ongoing) NL (Ongoing) IT (Prematurely Ended) CZ (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.